Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shanghai Wibson Biotechnology WBS

Shanghai Wibson Biotechnology WBS
Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP agonist) from Shanghai Wibson Biotechnology WBS between 9 Jun 2025 and 28 Aug 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
B
GOOD
Tentative Rating
Shanghai Wibson Biotechnology WBS
Tirzepatide
Tested 4 Samples
Last test 28 Aug 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Tirzepatide tests from top-rated vendors:

All Tirzepatide tests from Shanghai Wibson Biotechnology WBS

Samples are tested in commercial labs

Tests Count

4

Scores

AVG6.7MIN5.5MAX9.5

Last

28 Aug 2025

First

9 Jun 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
28 Aug 2025View9.530mg
33.1mg
32.500mg-1.8%99.95%T30 Orange TopNo Label / Silver Crimp / Orange CapLab EPublic
6 Aug 2025View5.930mg(no batch claim)33.850mg+12.8%99.89%(no batch ID)No Label / Silver Crimp / Orange Cap Lab FPublic
8 Jul 2025View5.530mg(no batch claim)34.820mg+16.1%99.98%(no batch ID)No Label / Silver Crimp / Yellow CapLab APublic
9 Jun 2025View5.915mg(no batch claim)14.000mg-6.7%99.22%(no batch ID)No Label / Silver Crimp / Red CapLab EPublic